-
Boryung to invest W24b in innovative US health care firms through Hayan I, L.P.IndustryJul 1, 2020Boryung Pharmaceutical said Wednesday it will make an incremental 24 billion won ($20 million) investment in innovative US health care firms. The investment will be carried out over three years by H... -
Samsung Display to mass-produce QD panels from 2021IndustryJul 1, 2020Samsung Display said Wednesday it anticipates to begin mass production of quantum-dot panels from 2021. The company held a celebratory event at its facility in Asan, South Chungcheong Province, wher... -
Yuhan in-licenses GI Innovation’s allergy treatment pipeline for $1.2bIndustryJul 1, 2020Yuhan Corp. announced Wednesday it has licensed GI Innovation’s next-generation allergy treatment pipeline in a deal that could potentially total $1.2 billion. “I am very pleased by this collaborat... -
Huons first Korean firm to export KF94 masks to WashingtonIndustryJun 30, 2020Huons Global said Tuesday that it will be the first South Korean firm to supply high-filtration masks to the state of Washington in the US. “This deal shows that Huons’ epidemic prevention products ... -
Merck starts next-gen semiconductor materials center in KoreaIndustryJun 30, 2020“Korea is an important innovation and production hub for Merck. We have invested more than 35 billion won ($29 million) to complete this technology center and expand our capabilities,” said Anand Nam... -
Hugel expects to launch Letybo in $1b European market by 2021IndustryJun 30, 2020Hugel expects to begin distributing its wrinkle-smoothening botulinum toxin in the $1 billion European market in mid-2021, the company announced Tuesday. Hugel and its European distribution partner,... -
Chunlab launches health care services centering on feces analyzationIndustryJun 30, 2020While emphasizing personalized probiotics and corresponding dietary scheme for holistic health care, Chunlab is also developing microbiome-originated pipelines for immuno-oncology, gastrointestinal d... -
NHN launches automated in-hospital messenger serviceIndustryJun 29, 2020Korean information technology firm NHN said Monday it has launched an automated in-hospital messenger service setting out to streamline medical professionals’ workflow. The system is optimal for cas... -
LabGenomics develops world’s first 35-minitue COVID-19 test kitIndustryJun 25, 2020LabGenomics, a molecular diagnostics health care company, developed the world’s first 35-minute real-time polymerase chain reaction test kit for COVID-19. The company’s shares, listed on the tech-he... -
Hanmi Science envisions ‘Cydio Cigma’ for post-COVID-19 eraIndustryJun 25, 2020Novel drugs developer Hanmi Science vowed Thursday to rev up its engine for Cydio Cigma -- six goals, standing for cyber education, digital bio, oral bio, city bio, green bio and marine Bio. “Where ... -
SK Biopharmaceuticals issues record-breaking IPOIndustryJun 24, 2020Investors were highly enthusiastic about the initial public offering of SK Biopharmaceuticals in the two-day retail tranche that wrapped up Wednesday, as it was oversubscribed 323 times with deposit ... -
![[팟캐스트] (358) 삐라는 무엇인가 / 코로나 실직자 제주도에 가장 많아](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2020/06/24/20200624000730_0.jpg)
[팟캐스트] (358) 삐라는 무엇인가 / 코로나 실직자 제주도에 가장 많아PodcastJun 24, 2020진행: 임정요, Kevin Lee Selzer 1. Leafleting: decisive propaganda or empty provocation? 아이튠즈(아이폰): https://itunes.apple.com/kr/podcast/koliaheleoldeu-paskaeseuteu/id686406253?mt=2 팟빵 (안드로이드): http://... -
Samsung Biologics achieves 95.57% of last year’s revenue in June aloneIndustryJun 24, 2020Samsung Biologics shares started upbeat Wednesday morning, up 2.62 percent from a day before, in light of its disclosure that it has nabbed a contract manufacturing deal worth $314 million with a Eur... -
Celltrion shares upbeat after Italian COVID-19 patient recovers with RemsimaIndustryJun 23, 2020Celltrion shares rose 7.58 percent on Tuesday, following news that an Italian COVID-19 patient tested negative for the virus a week after being treated with Celltrion’s autoimmune disease treatment R... -
Boryung’s innovative cancer treatment ‘more potent’ than existing PI3KsIndustryJun 23, 2020Boryung Pharmaceutical presented the outcomes of the preclinical tests of its innovative blood cancer treatment on Tuesday at the American Association for Cancer Research, saying that the BR101801 pi...
MOST POPULAR
-
01Gwangju fears becoming next Daegu
-
Virus spread outside capital accelerates; local infections at 2-week high02
-
03Health officials continue to give grim warning over COVID-19
-
Cold case cracked? Police own up to past brutality, close probe on notorious serial killings04
-
05[Newsmaker] Calls grow for probe of abuse allegations after triathlete’s suicide
-
[News Focus] Sejong sees population fall for 1st time in history06
-
07S. Korea confirms first virus spread at school
-
[Herald Interview] ‘Australian English as prestigious as American English’08
-
09[Newsmaker] S. Korea begins using remdesivir to treat COVID-19
-
NK named 39th most dangerous country in world10